Shu Qin-Meng, Ju Yu-Qiao, Zong Yuan, Zhang Ting, Huang Xin, Gao Feng-Juan, Chang Qing
Eye Institute, Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China.
Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, China.
Hum Genomics. 2025 Apr 9;19(1):38. doi: 10.1186/s40246-025-00749-2.
This study aimed to elucidate the reliability of clinical impressions based on ocular manifestations in patients suspected of heritable connective tissue disorders (HCTDs) compared to the final genetic diagnosis. Furthermore, it sought to determine the optimal diagnostic strategy for patients with HCTDs through pathogenicity analysis.
Clinical characteristics of 58 patients suspected of HCTDs were analyzed to establish provisional clinical diagnoses. Subsequently, next-generation sequence and Sanger sequence was performed to obtain genetic diagnoses. Pathogenicity of identified variants was assessed through conservation analysis and the functional impact, which was predicted using three-dimensional protein structure modeling.
The provisional clinical diagnosis was concordant with the molecular diagnostic result in only 21 patients. Independent of the initial clinical impression, a probable genetic diagnosis was achieved for all 58 patients following comprehensive re-analysis of next-generation sequence data, combined with pathogenicity assessment using three-dimensional protein structure and conservation analysis of suspicious positive variants.
This study broadens the mutational spectrum of HCTDs with 31 novel variants. By employing innovative methodologies to delineate phenotype-genotype relationships, including the detection of potentially pathogenic variants, this work may inform future diagnostic strategies and guide comprehensive disease and organ system monitoring. Ongoing refinement and vigilant clinical oversight remain essential for patients and their families.
本研究旨在阐明与最终基因诊断相比,基于疑似遗传性结缔组织病(HCTD)患者眼部表现的临床印象的可靠性。此外,通过致病性分析确定HCTD患者的最佳诊断策略。
分析58例疑似HCTD患者的临床特征以建立初步临床诊断。随后,进行二代测序和桑格测序以获得基因诊断。通过保守性分析和功能影响评估鉴定变异的致病性,利用三维蛋白质结构建模进行预测。
仅21例患者的初步临床诊断与分子诊断结果一致。在对二代测序数据进行全面重新分析,并结合使用三维蛋白质结构进行致病性评估和对可疑阳性变异进行保守性分析后,所有58例患者均获得了可能的基因诊断,与最初的临床印象无关。
本研究通过31个新变异拓宽了HCTD的突变谱。通过采用创新方法来描绘表型-基因型关系,包括检测潜在致病性变异, 这项工作可能为未来诊断策略提供信息,并指导全面的疾病和器官系统监测。对患者及其家庭而言,持续的改进和警惕的临床监督仍然至关重要。